Skip to main content
Premium Trial:

Request an Annual Quote

Immune Tolerance Network Chooses Expression Analysis as Microarray Core Facility

NEW YORK, Jan. 25 (GenomeWeb News) - The Immune Tolerance Network has chosen Expression Analysis to serve as its microarray core facility, the company said today.


Using Affymetrix GeneChips, EA over the next 20 months will help support clinical trials for the ITN, an international collaborative research project involving more than 70 scientists and clinical professionals.

Terms of the deal call for EA to provide the ITN with a single-source environment for processing clinical trials samples submitted from multiple locations. EA said it expects to process several thousand clinical samples during the initial contract period.

Founded in Durham, NC, in 2001, EA offers high-throughput sample processing and statistical support for microarray-based gene-expression, genotyping, and resequencing.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.